BlackRock Investment Management, LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 39 filers reported holding CYTOSORBENTS CORP in Q4 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q4 2016$21,000
-12.5%
3,7760.0%0.00%
Q3 2016$24,000
+41.2%
3,7760.0%0.00%
Q2 2016$17,000
+70.0%
3,776
+45.7%
0.00%
Q1 2016$10,000
-28.6%
2,5910.0%0.00%
Q4 2015$14,000
-6.7%
2,591
+7.4%
0.00%
Q3 2015$15,0000.0%2,4130.0%0.00%
Q2 2015$15,0002,4130.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2015
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders